Evidence map›Paper›PMID 37958677›Full record

SynthesisInternational journal of molecular sciences2023

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer.

Cinzia Giordano, Felice Maria Accattatis, Luca Gelsomino, Piercarlo Del Console, Balázs Győrffy, Mario Giuliano, Bianca Maria Veneziani, Grazia Arpino, Carmine De Angelis, Pietro De Placido and 6 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Cinzia GiordanoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
Felice Maria AccattatisDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
Luca GelsominoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
Piercarlo Del ConsoleDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
Balázs GyőrffyDepartments of Bioinformatics and Pediatrics, Semmelweis University, 1094 Budapest, Hungary.ORCID 0000-0002-5772-3766
Mario GiulianoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80133 Naples, Italy.
Bianca Maria VenezianiDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80133 Naples, Italy.ORCID 0000-0002-1678-4183
Grazia ArpinoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80133 Naples, Italy.ORCID 0000-0002-4074-2530
Carmine De AngelisDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80133 Naples, Italy.
Pietro De PlacidoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80133 Naples, Italy.
Erica PietroluongoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, 80133 Naples, Italy.
Francesco ZinnoImmunohaematology and Transfusion Medicine, A.O. "Annunziata", 87100 Cosenza, Italy.
Daniela BonofiglioDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.ORCID 0000-0002-4142-0496
Sebastiano AndòDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
Ines BaroneDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.ORCID 0000-0002-9769-1615
Stefania CatalanoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via P. Bucci, Arcavacata di Rende (CS), 87036 Cosenza, Italy.
University of Calabria · ITUniversity of Naples Federico II · ITOspedale Annunziata di Cosenza · ITSemmelweis University · HU

Funding

Italian Association for Cancer Research IG #21414Italian Association for Cancer Research IG #26246Ministero dell'università e della Ricerca, Italia BANDO PRIN 2017 #2017WNKSLR_005Ministero dell'Università e della Ricerca, Italia PRIN 2017 #2017EKMFTN_001Ministero dell'Università e della Ricerca, Italia PRIN 2017 #2017EKMFTN_006National Research, Development and Innovation Office PharmaLab, RRF-2.3.1-21-2022-00015 and TKP2021-NVA-15Sistema Integrato di Laboratori per L'Ambiente-(SILA) PONa3_00341
6 · The paper itself

Abstract

Circulating extracellular vesicle (EV)-derived microRNAs (miRNAs) are now considered the next generation of cancer "theranostic" tools, with strong clinical relevance. Although their potential in breast cancer diagnosis has been widely reported, further studies are still required to address this challenging issue. The present study examined the expression profiles of EV-packaged miRNAs to identify novel miRNA signatures in breast cancer and verified their diagnostic accuracy. Circulating EVs were isolated from healthy controls and breast cancer patients and characterized following the MISEV 2018 guidelines. RNA-sequencing and real-time PCR showed that miRNA-27a and miRNA-128 were significantly down-regulated in patient-derived EVs compared to controls in screening and validation cohorts. Bioinformatics analyses of miRNA-target genes indicated several enriched biological processes/pathways related to breast cancer. Receiver operating characteristic (ROC) curves highlighted the ability of these EV-miRNAs to distinguish breast cancer patients from non-cancer controls. According to other reports, the levels of EV-miRNA-27a and EV-miRNA-128 are not associated with their circulating ones. Finally, evidence from the studies included in our systematic review underscores how the expression of these miRNAs in biofluids is still underinvestigated. Our findings unraveled the role of serum EV-derived miRNA-27a and miRNA-128 in breast cancer, encouraging further investigation of these two miRNAs within EVs towards improved breast cancer detection.

Indexed as

Breast NeoplasmsExtracellular VesiclesMicroRNAsFemaleHumansMicroRNAsbreast cancerextracellular vesiclesmiRNA-128miRNA-27amiRNAs

Identifiers

PMID37958677
PMCPMC10649351
OpenAlexW4388021289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.